Co-Authors
This is a "connection" page, showing publications co-authored by Richard Meenan and Amanda Petrik.
Connection Strength
0.470
-
Costs of Two Health Insurance Plan Programs to Mail Fecal Immunochemical Tests to Medicare and Medicaid Plan Members. Popul Health Manag. 2021 04; 24(2):255-265.
Score: 0.184
-
A cost-effectiveness analysis of a colorectal cancer screening program in safety net clinics. Prev Med. 2019 Mar; 120:119-125.
Score: 0.166
-
Health plan-based mailed fecal testing for colorectal cancer screening among dual-eligible Medicaid/Medicare enrollees: Outcomes of 2 program models. Cancer. 2022 Jan 15; 128(2):410-418.
Score: 0.050
-
Positive predictive values of fecal immunochemical tests used in the STOP CRC pragmatic trial. Cancer Med. 2018 Sep; 7(9):4781-4790.
Score: 0.040
-
Strategies and Opportunities to STOP Colon Cancer in Priority Populations: design of a cluster-randomized pragmatic trial. Contemp Clin Trials. 2014 Jul; 38(2):344-9.
Score: 0.030